APA

Borrás Pérez V., López-Siguero J. P., Martínez G., Corripio R., Fernández J. M., Labarta J. I., Ferrer M., Cabrinety N., Prieto P., Ramón-Krauel M., Bosch J., Espino R., Palla Garcia M. & Rebollo F. J. (20160323). A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial. : Advances in therapy.

Chicago

Borrás Pérez Victoria, López-Siguero Juan Pedro, Martínez Gabriela, Corripio Raquel, Fernández Juan Manuel, Labarta Jose Ignacio, Ferrer Marta, Cabrinety Nuria, Prieto Pablo, Ramón-Krauel Marta, Bosch Jordi, Espino Rafael, Palla Garcia Margarida and Rebollo Francisco Jose. 20160323. A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial. : Advances in therapy.

Harvard

Borrás Pérez V., López-Siguero J. P., Martínez G., Corripio R., Fernández J. M., Labarta J. I., Ferrer M., Cabrinety N., Prieto P., Ramón-Krauel M., Bosch J., Espino R., Palla Garcia M. and Rebollo F. J. (20160323). A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial. : Advances in therapy.

MLA

Borrás Pérez Victoria, López-Siguero Juan Pedro, Martínez Gabriela, Corripio Raquel, Fernández Juan Manuel, Labarta Jose Ignacio, Ferrer Marta, Cabrinety Nuria, Prieto Pablo, Ramón-Krauel Marta, Bosch Jordi, Espino Rafael, Palla Garcia Margarida and Rebollo Francisco Jose. A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial. : Advances in therapy. 20160323.